Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

18.98
BATS BZX Real-Time Price
As of 12:42pm ET
 -0.27 / -1.40%
Today’s Change
7.32
Today|||52-Week Range
27.09
+91.33%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close19.25
Today’s open19.13
Day’s range18.59 - 19.25
Volume10,770
Average volume (3 months)993,542
Market cap$913.4M
Dividend yield--
Data as of 12:42pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+20.97%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.35-1.29%
ATNXAthenex Inc+0.01+0.06%
DERMDermira Inc+0.02+0.07%
CLLSCellectis SA-0.43-1.56%
Data as of 12:40pm ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts